Seminars in Immunopathology

Papers
(The median citation count of Seminars in Immunopathology is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Learning cell identity in immunology, neuroscience, and cancer150
Micro-to multi-chimerism: the multiple facets of a singular phenomenon125
Complement & disease: out of the shadow into the spotlight117
Vascular galectins in tumor angiogenesis and cancer immunity114
Halting targeted and collateral damage to red blood cells by the complement system112
Adaptive immunity, chronic inflammation and the clock99
Role of polyamines in intestinal mucosal barrier function95
Combination immunotherapy with synthetic long peptides and chemotherapy or PD-1 blocker for cancers caused by human papilloma virus type 1692
Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors76
Diseases of blood vessels: Immune system involvement in vasculitis and vasculopathy73
Regulatory T lymphocytes as a therapy for ischemic stroke69
Genetics and functional genomics of multiple sclerosis56
The mucosal immune system and IgA nephropathy54
Immune checkpoint for pregnancy52
Correction: Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity49
Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation46
IgA glycosylation and immune complex formation in IgAN46
Correction to: Narcolepsy: a model interaction between immune system, nervous system, and sleep-wake regulation46
Thromboinflammatory challenges in stroke pathophysiology44
Genetics of rheumatoid arthritis41
The role of vaccines in the COVID-19 pandemic: what have we learned?41
The emerging role of complement in neuromuscular disorders41
Publisher Correction: Epithelial recognition and elimination against aberrant cells40
Towards multiomic analysis of oral mucosal pathologies38
The duality of microchimerism and cancer in parous women: a review and evolutionary perspective37
Cap analysis of gene expression (CAGE) and noncoding regulatory elements37
Gut instincts in neuroimmunity from the eighteenth to twenty-first centuries37
Clinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation36
Immunization of preterm infants: current evidence and future strategies to individualized approaches35
Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus35
Are there animal models of IgA nephropathy?35
The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy33
Glucocorticoid circadian rhythms in immune function33
The role of microglia in early neurodevelopment and the effects of maternal immune activation33
Complement as driver of systemic inflammation and organ failure in trauma, burn, and sepsis33
Tolerance and autoimmunity in the liver32
IgA nephropathy: a perspective for 202131
TNF in the liver: targeting a central player in inflammation29
Current treatment of IgA nephropathy29
Single-cell RNA-seq methods to interrogate virus-host interactions29
Dyslipidemia and female reproductive failures: perspectives on lipid metabolism and endometrial immune dysregulation28
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy27
CAF-immune cell crosstalk and its impact in immunotherapy27
Correction to: MAIT cells in liver inflammation and fibrosis26
The aging immune system in Alzheimer’s and Parkinson’s diseases26
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection25
Revisiting transplant immunology through the lens of single-cell technologies25
Unveiling the immunopathology of stroke: a comprehensive view on brain-immune interaction24
Beyond defence: Immune architects of ovarian health and disease24
Tissue-resident immunity in the female and male reproductive tract24
Arginine metabolism in myeloid cells in health and disease24
CAR T-cell behavior and function revealed by real-time imaging24
Eosinophils and helminth infection: protective or pathogenic?22
Local anesthetics and immunotherapy: a novel combination to fight cancer22
Circadian regulation of innate immunity in animals and humans and implications for human disease22
Role of bile acids in inflammatory liver diseases22
B cells in autoimmune hepatitis: bystanders or central players?21
Complement activation in IgA nephropathy21
Mothers and mosquitoes: climate change contributes to the spread of vector-borne pathogens posing a substantial threat to pregnant women21
Complement in metabolic disease: metaflammation and a two-edged sword20
Role of mucosal IgA antibodies as novel therapies to enhance mucosal barriers20
Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition20
Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)20
Immune compartments at the brain’s borders in health and neurovascular diseases19
Correction to: Cellular senescence in the cholangiopathies: a driver of immunopathology and a novel therapeutic target19
Beyond direct killing—novel cellular immunotherapeutic strategies to reshape the tumor microenvironment19
Correction to: Complement in ischaemia–reperfusion injury and transplantation19
Functional interrogation of autoimmune disease genetics using CRISPR/Cas9 technologies and massively parallel reporter assays19
Harnessing the liver to induce antigen-specific immune tolerance18
How genetic risk contributes to autoimmune liver disease18
Role of alarmins in poststroke inflammation and neuronal repair17
Intertwining roles of circadian and metabolic regulation of the innate immune response17
Tipping the balance: intricate roles of the complement system in disease and therapy17
Role of glia and extracellular matrix in controlling neuroplasticity in the central nervous system16
Disease pathogenesis and barrier functions regulated by group 3 innate lymphoid cells16
Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy16
Gut microbiota-derived metabolites tune host homeostasis fate16
Challenges and opportunities in achieving effective regulatory T cell therapy in autoimmune liver disease16
Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology15
Unveiling the gut-brain axis: structural and functional analogies between the gut and the choroid plexus vascular and immune barriers15
Proteomics to study cancer immunity and improve treatment14
The role of circulating cell-free DNA as an inflammatory mediator after stroke14
Neuroimaging is the new “spatial omic”: multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke14
COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells14
Tumor microenvironment antigens14
Circadian rhythms in adaptive immunity and vaccination14
Glycoprotein 2 as a gut gate keeper for mucosal equilibrium between inflammation and immunity13
The sweet and the bitter sides of galectin-1 in immunity: its role in immune cell functions, apoptosis, and immunotherapies for cancer with a focus on T cells13
Mechanisms of vascular damage in ANCA vasculitis13
Intracellular galectin interactions in health and disease13
Cell therapies for viral diseases: a new frontier13
The microbiome and IgA nephropathy12
Role of Hyaluronic acid and its chemical derivatives in immunity during homeostasis, cancer and tissue regeneration12
The role of the mucosal barrier system in maintaining gut symbiosis to prevent intestinal inflammation12
Lessons (to be) learned from liquid biopsies: assessment of circulating cells and cell-free DNA in cancer and pregnancy-acquired microchimerism12
Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment12
Heterogeneity of tissue-resident immunity across organs and in health and disease12
Physiological and immunological barriers in the lung12
0.031321048736572